Neurometabolic Diseases Lab

  • Increase font size
  • Default font size
  • Decrease font size
Home Lines of Research Publications
Publications
Title Filter     Display # 
# Article Title Hits
41 Neurochemistry and the non-motor aspects of PD. Neurobiol Dis. 2012 Jun;46(3):508-26. 478
42 Antioxidants Halt Axonal Degeneration in a Mouse Model of X-Adrenoleukodystrophy. ANN NEUROL 2011;70:84–92 810
43 Phylogenomic evidence for a myxococcal contribution to the mitochondrial fatty acid beta-oxidation.PLoS One. 2011;6(7):e21989. 675
44 Oxidative Damage Compromises Energy Metabolism in the Axonal Degeneration Mouse Model of X-Adrenoleukodystrophy. Antioxid Redox Signal. 2011 Oct 15;15(8):2095-107 1093
45 Invariant NKT cells in adrenoleukodystrophy patients and mice.J Neuroimmunol. 2010 Dec 15;229(1-2):204-11. 873
46 Staging anti-inflammatory therapy in Alzheimer's disease. Front Aging Neurosci. 2010 Oct 25;2:142. 833
47 Current and Future Pharmacological Treatment Strategies in X-Linked Adrenoleukodystrophy. MINI-SYMPOSIUM: X - Linked Adrenoleukodystrophy. Brain Pathol. 2010 Jul;20(4):845-56. 1213
48 Pathomechanisms Underlying X-Adrenoleukodystrophy: A Three-Hit Hypothesis. MINI-SYMPOSIUM: X - Linked Adrenoleukodystrophy. Brain Pathol. 2010 Jul;20(4):838-44. 929
49 General Aspects and Neuropathology of X-Linked Adrenoleukodystrophy. MINI-SYMPOSIUM: X - Linked Adrenoleukodystrophy. Brain Pathol. 2010 Jul;20(4):817-30. 1200
50 Schilder's disease a heterogenous group of disorders known as X-linked adrenoleukodystrophy. Foreword.. MINI-SYMPOSIUM: X - Linked Adrenoleukodystrophy. Brain Pathol. 2010 Jul;20(4):815-6. 918
51 Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy. Hum Mol Genet. 2010 May 15;19(10):2005-14. Epub 2010 Feb 23. 1089
52 PeroxisomeDB 2.0: an integrative view of the global peroxisomal metabolome. Nucleic Acids Res. 2010 Jan;38(Database issue):D800-5. 1849
53 Insulin-like Growth Factor-1 and Neurotrophin-3 Gene Therapy Prevents Motor Decline in an X-Linked Adrenoleukodystrophy Mouse Model. ANNALS OF NEUROLOGY. 66, 1, 117-122 (2009) 931
54 ABCD2 is abundant in adipose tissue and opposes the accumulation of dietary erucic acid (C22:1) in fat. J Lipid Res. 2010 Jan;51(1):162-8. 1373
55 A key role for the peroxisomal Abcd2 transporter in fatty acid homeostasis. American Journal of Physiology. Endocrinology and Metabolism. 296(1):E211-21. (2009) 987
56 Early oxidative damage underlying neurodegeneration in Xadrenoleukodystrophy. Human Molecular Genetics. Jun 15;17(12):1762-73 (2008) 919
57 Steroid hormones control circadian Elovl3 expression in mouse liver. Endocrinology. Jun;149(6):3158-66 (2008) 974
58 The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of ABCD2 (Aldr), not ABCD1 (ALD) causes oxidative damage. Laboratory Investigation. (2007) 1-12 (2007) 1215
59 PeroxisomeDB: a database for the peroxisomal proteome, functional genomics and disease. Nucleic Acids Research. Jan 35, D815-22 (2007) 1730
60 The Evolutionary Origin of Peroxisomes:An ER-Peroxisome connection. Molecular Biology and Evolution. 23(4):838-845 (2006) 1721
 
Page 3 of 4

View My Stats